Inhibitor | Target site | Mode of inhibition of STAT3 function | Cellular effects | References |
---|---|---|---|---|
PY*LKTK | domain SH2 | Dimerization | ↓ Malignant cell growth and transformation | Turkson et al. (2001) |
Y*LPQTV | domain SH2 | Dimerization | ND | Ren et al. (2003) |
SS610 | domain SH2 | Dimerization | ↓ Malignant cell growth and transformation | Turkson et al. (2004) |
↑ Apoptosis | ||||
S3I-M2001 | domain SH2 | Dimerization | ↓ Malignant cell growth | Siddiquee et al. (2007) |
↑ Apoptosis, ↓ Migration | ||||
STA-21 | domain SH2 | Dimerization | ↑ Apoptosis | Song et al. (2005) |
S3I-201 | domain SH2 | Dimerization | ↓ Cell growth | Siddiquee et al. (2007) |
↑ Apoptosis | ||||
Stattic | domain SH2 | Phosphorylation | ↑ Apoptosis | Schust et al. (2006) |
Catechol-containing compounds | domain DBD | DNA-binding | ND | Hao et al. (2008) |
IS3 295 | domain DBD | DNA-binding | ↓ Cell growth | Turkson et al. (2005) |
↑ Apoptosis | ||||
CPA-1, CPA-7 | domain DBD | DNA-binding | ↓ Cell growth | Turkson et al. (2004) |
↑ Apoptosis | ||||
Galiellalactone | domain DBD | DNA-binding | ↓ Cell growth | Weidler et al. (2000) |
↑ Apoptosis | ||||
Peptide aptamers | domain DBD | DNA-binding | ↓ Cell growth | Nagel-Wolfrum et al. (2004) |
↑ Apoptosis | ||||
Decoy ODN | domain DBD | Compete against endogenous DNA cis element | ↓ Cell growth | Leong et al. (2003) |
↑ Apoptosis | ||||
G-quartet ODN | domain SH2 | Phosphorylation | ↓ Cell growth | Jing et al. (2006) |
↑ Apoptosis | ||||
Peptides | ND | Transcriptional activity | ↓ Cell growth | Timofeeva et al. (2007) |
↑ Apoptosis | ||||
JSI-124 & derivatives | JAK? | Phosphorylation | ↓ Cell growth | Blaskovich et al. (2003) |
↑ Apoptosis, ↓ invasiveness | ||||
Withacnistin | JAK? | Phosphorylation | ↓ Proliferation, ↑ apoptosis | Sun et al. (2005) |